
Opinion|Videos|February 5, 2024
Medication Assistance Programs Mitigating Financial Burden For Patients Receiving Bispecific Therapy
Experts underscore cost relief of bispecific antibodies via medication assistance programs.
Advertisement
The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.
Video synopsis is AI-generated and reviewed by AJMC editorial staff.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Weight Loss Medications Show Promise in MASLD, MASH
3
HMA Combination Therapy Boosts Survival in Accelerated- or Blast-Phase MPNs
4
How Medicaid Reforms Could Deepen State Coverage Gaps
5